Juvenile Idiopathic Arthritis in Children in Estonia.

Epidemiology Clinical Trial

Official title:

Juvenile Idiopathic Arthritis in Children in Estonia - an Epidemiological and Clinical Investigation.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01905319
• Other study ID #: TARLA 0475;DARLA 0500
• Status: Completed
• Start date: January 1998
• Est. completion date: December 2002

Study information

• Verified date: March 2020
• Source: University of Tartu
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Aims of the study:

• to study the incidence rate of juvenile idiopathic arthritis (JIA) and it's clinical subtypes in Estonia for the years 1998-2000;

• to examine the course and short-term clinical outcome of JIA.

Method: a prospective population-based study carried on in 14 counties of Estonia

Recruitment information / eligibility

• Status: Completed
• Enrollment: 162
• Est. completion date: December 2002
• Est. primary completion date: December 2000
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Month to 15 Years

Eligibility

Inclusion Criteria:

• The International League of Associations for Rheumatology (ILAR) criteria for juvenile idiopathic arthritis

• children aged 0-15 years who had arthritis of an unknown cause for at least six weeks with an onset of the disease during the study period

Exclusion Criteria:

• Children with infectious arthritis, postinfectious arthritis, traumatic arthritis and systemic connective tissue diseases

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Juvenile
• Epidemiology

Intervention

Other:
• Blood collecting for storage of samples

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Tartu

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean annual incidence rate of juvenile idiopathic arthritis in Estonia during years 1998-2000.		3 years